As the incidence of childhood obesity continues to dramatically increase, the emergence of type 2 and the increasing incidence of type 1 diabetes in young people demonstrate that childhood diabetes, like adult onset diabetes, is a complex and heterogeneous condition presenting new obstacles to the practicing clinician. Epidemiology of...

Over the next decade, the global number of people with diabetes and at risk of diabetes and cardiovascular disease is expected to grow by 25%, largely driven by the rising prevalence of obesity and inactivity. The problem is especially serious in Asia, where the WHO predicts that in less than a decade, 60% of the worldwide population with...

The Business Case for Network Security: Advocacy, Governance, and ROI addresses the needs of networking professionals and business executives who seek to assess their organization's risks and objectively quantify both costs and cost savings related to network security technology investments....

After reviewing the history of cancer and its impact on the population, Dr. Faguet exposes the antiquated notions that have driven cancer drug development, documents the stagnation in treatment outcomes despite major advances in cancer genomics and growing NCI budgets, and identifies the multiple factors that sustain the status quo. He shows...

This is a comprehensive handbook on all aspects of adverse effects by drugs, chemical substances and radiation on the kidneys. The book consists of a general part dealing with themes such as clinical relevance, renal handling and cellular mechanisms of nephrotoxicity, as well as animal and cell culture models. The second part includes the...

This book is organized into 4 sections, each looking at the question of outcome prediction in cancer from a different angle. The first section describes the clinical problem and some of the predicaments that clinicians face in dealing with cancer. Amongst issues discussed in this section are the TNM staging, accepted methods for survival...